The analysis of thyroid hormones and antibodies together may improve the accuracy diagnosis and clinical success. The American Thyroid Association estimates that approximately 20 million Americans have thyroid disease, and approximately 60% of those with thyroid disease are unaware of their condition. Many patients with thyroid disorders may remain undiagnosed in many patients with asymptomatic or non-specific clinical presentations. The recognition of auto-immunity as a leading cause of thyroid dysfunction has led to the evaluation of auto-antibodies in thyroid testing.
Measuring only thyroid stimulating hormone (TSH) may be misleading in a variety of circumstances, including the recent treatment of thyrotoxicosis, pituitary disease, non-thyroid illness, thyroid hormone resistance or rare, TSH-secreting tumors. Under these circumstances, and in many other cases, the evaluation of thyroid hormones and thyroid antibodies may clarify the diagnosis of thyroid conditions and improve clinical success.
[ LEARN MORE]
2 to 3 days
Note: Turnaround times on results are an estimate and are not guaranteed. The lab may need additional time due to holidays, confirmation/repeat testing, etc. You can contact us to discuss when your results should be ready.
Click any analyte name for additional clinical information, including reference ranges, specimen collection, stability and rejection criteria.
List price applies when filing with insurance or Medicare, or when billing a patient directly. Prompt payment pricing applies when billing to a physician account or prepayment is received with the test.
Doctor's Data offers profiles containing multiple analytes. *Multiple analytes may be billed under a single CPT code. Many analytes can be ordered individually. Pricing may vary. Click on a specific analyte for more information or read our detailed billing and payment policies.
The CPT codes listed on our website are for informational purposes only. This information is our interpretation of CPT coding requirements and may not necessarily be correct. You are advised to consult the CPT Coding Manual published by the American Medical Association. Doctor's Data, Inc. takes no responsibility for billing errors due to your use of any CPT information from our website.
Sign in at the top of any page to view pricing and order tests. Or click here to create an account. You may also contact us for assistance placing an order.
The analysis of thyroid hormones and antibodies together may improve the accuracy of diagnosis and clinical success. The American Thyroid Association estimates that approximately 20 million Americans have thyroid disease, and approximately 60% of those with thyroid disease areunaware of their condition. Many patients with thyroid disorders may remain undiagnosed in many patients with asymptomatic or non-specific clinical presentations.
Patients with conditions such as osteoporosis, dyslipidemia, atrial fibrillation, or infertility may be evaluated for thyroid disorders. Current recommendations for diabetic women planning pregnancies include a full thyroid panel with antibodies preconception, with monitoring during pregnancy and three months post-partum.
Measuring only thyroid stimulating hormone (TSH) may be misleading in a variety of circumstances, including the recent treatment of thyrotoxicosis, pituitary disease, non-thyroid illness, thyroid hormone resistance and rare TSH-secreting tumors. Joshi (2011) recommends monitoring free T3 and T4 in patients with low serum TSH levels, to establish patterns of increasing or decreasing values over time. The main purpose of free-T4 and free-T3 assays is to discern thyrotoxicosis from hypothyroidism and the euthyroid state. Less than one percent of thyroid hormone is free unbound hormone; this one percent is the biologically active fraction. Total T4 and T3 values cannot reliably distinguish between these conditions due to hereditary and acquired variations in the concentrations of thyroid hormone binding proteins. Measuring T3 levels during treatment with antithyroid medication may have predictive value in the management of autoimmune thyroiditis, such as Grave’s disease.
The recognition of auto-immunity as a leading cause of thyroid dysfunction has led to the evaluation of auto-antibodies in thyroid testing. Thyroid antibody tests are used to distinguish autoimmune thyroid disorders from other thyroid dysfunction. Thyroid antibody tests, such as thyroid peroxidise antibodies (TPOAb) and thyroglobulin antibodies (TgAb), are most important in patients with other, pre-existing autoimmune conditions, for example, systemic lupus erythematosus, rheumatoid arthritis, and Celiac disease.
Elevations of thyroid antibodies or low levels of thyroid hormones may prompt the evaluation of iodine and selenium status, as iodine deficiency may be exacerbated by deficiencies of selenium, iron or Vitamin A. Iodine is an essential component of thyroid hormones, and iodine deficiency is a world-wide health problem. Declining levels of urinary iodine in the US population has been documented by Centers for Disease Control and Prevention (CDC, 2002). The enzymes that convert T3 to T4 are selenium dependent. Low selenium levels have been associated with goiter and thyroid nodules in European women.
The evaluation of thyroid hormones and thyroid antibodies is an opportunity to discover and treat the functional cause of vague symptoms and chronic complaints. The analysis of thyroid hormones and antibodies together may improve the accuracy of diagnosis and clinical success.
| View Sample Report | |
| Collection Instructions | |
| Detailed Information | |